Molecular You
Molecular You is a pioneer in predictive, preventative, and precision health, providing advanced molecular analysis to empower individuals and healthcare providers with actionable health insights. Founded in 2014 as a spin-off from the Personalized Medicine Initiative in Vancouver, BC, the company leverages cutting-edge proteomics, metabolomics, and AI to analyze over 250 blood-based biomarkers. Their mission is to make molecular medicine simple, accessible, and impactful, enabling early detection of disease risks and supporting personalized, data-driven health decisions. Molecular You serves both clinics and individuals, offering comprehensive health assessments, personalized action plans, and ongoing progress tracking to foster proactive, transparent, and preventative care. The company’s platform is rooted in rigorous scientific validation, peer-reviewed research, and advanced multi-omic analysis, setting a new standard for precision health and population health management. Molecular You’s unique systems biology approach analyzes interconnected pathways—such as metabolic, cardiovascular, immune, neurological, and hormonal health—providing a holistic view of health that goes far beyond traditional lab tests. Their direct-to-consumer platform enables at-home blood draws and digital health dashboards, and their Action Plan translates biomarker data into tailored, science-backed recommendations for diet, supplements, and lifestyle. The platform’s comprehensive biomarker coverage and AI-driven insights empower both patients and providers to detect and address health concerns long before symptoms arise.
Industries
N/A
Nr. of Employees
small (1-50)
Molecular You
#307-788 Beatty Street, Vancouver, British Columbia, Canada V6B 2M1
Products
Comprehensive multi-omic blood assay (250+ biomarkers)
Single-sample blood assay that quantifies over 250 proteins, metabolites and related biomarkers across metabolic, inflammatory, cardiovascular, neurological and immune systems to generate risk profiles, pathway analyses and disease-area scores.
Provider analytics portal
Cloud-based dashboard for clinicians to view patient biomarker results, trend dashboards, pathway and disease-area scores, and downloadable reports suitable for integration into clinical records.
Patient mobile application for reports and action plans
Mobile application providing individuals secure access to biomarker reports, personalized action plans, and progress tracking between tests.
Biomarker categorization guide (downloadable)
Reference document mapping biomarker associations to diseases and biological pathways intended to support clinical interpretation and research use.
Comprehensive multi-omic blood assay (250+ biomarkers)
Single-sample blood assay that quantifies over 250 proteins, metabolites and related biomarkers across metabolic, inflammatory, cardiovascular, neurological and immune systems to generate risk profiles, pathway analyses and disease-area scores.
Provider analytics portal
Cloud-based dashboard for clinicians to view patient biomarker results, trend dashboards, pathway and disease-area scores, and downloadable reports suitable for integration into clinical records.
Patient mobile application for reports and action plans
Mobile application providing individuals secure access to biomarker reports, personalized action plans, and progress tracking between tests.
Biomarker categorization guide (downloadable)
Reference document mapping biomarker associations to diseases and biological pathways intended to support clinical interpretation and research use.
Expertise Areas
- Multi-omic biomarker profiling
- Targeted quantitative mass spectrometry and targeted proteomics
- Targeted metabolomics and lipidomics
- Longitudinal biomarker monitoring and trend analytics
Key Technologies
- Targeted LC‑MS/MS (MRM)
- Stable isotope-labeled internal standards
- Targeted proteomics
- Targeted metabolomics and lipidomics
Key People
CEO
CSO + President, Co-founder
Chief Informatics Officer, Co-founder
Chief Medical Officer
Chief Lab Analytics Officer, Co-founder
CEO
CSO + President, Co-founder
Chief Informatics Officer, Co-founder
Chief Medical Officer
Chief Lab Analytics Officer, Co-founder
News & Updates
Molecular You’s platform enabled the early detection of stage 1 pancreatic cancer in a symptom-free patient, leading to successful intervention and demonstrating the real-world, life-saving potential of multi-omic biomarker analysis.
Received for advancing personalized health technologies in collaboration with The Metabolomics Innovation Centre (TMIC).
Recognized for commitment to innovative health solutions in the longevity sector.
Explains how comprehensive biomarker testing provides a multidimensional view of health, supporting early intervention and personalized care.
Discusses how stress impacts biological aging, with biomarkers providing insight into physiological changes and health risks.
Explores the role of blood-based biomarkers in early detection and monitoring of autoimmune diseases, supporting more personalized and timely interventions.
Molecular You’s platform enabled the early detection of stage 1 pancreatic cancer in a symptom-free patient, leading to successful intervention and demonstrating the real-world, life-saving potential of multi-omic biomarker analysis.
Received for advancing personalized health technologies in collaboration with The Metabolomics Innovation Centre (TMIC).
Recognized for commitment to innovative health solutions in the longevity sector.
Explains how comprehensive biomarker testing provides a multidimensional view of health, supporting early intervention and personalized care.
Discusses how stress impacts biological aging, with biomarkers providing insight into physiological changes and health risks.
Explores the role of blood-based biomarkers in early detection and monitoring of autoimmune diseases, supporting more personalized and timely interventions.